Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II

K-Number: K153301 · 2016-04-08

ApplicantRoche Diagnostics
Decision Date2016-04-08
Product CodeKXT
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II is the device name listed in this FDA 510(k) record. The listed applicant is Roche Diagnostics. It received FDA 510(k) clearance on 2016-04-08 under 510(k) number K153301. The device is classified under product code KXT. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II?

Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II is a medical device that received FDA 510(k) clearance on 2016-04-08. The listed applicant is Roche Diagnostics. The 510(k) number is K153301.

When did Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II receive FDA 510(k) clearance?

Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II received FDA 510(k) clearance on 2016-04-08, under 510(k) number K153301.

Who is the listed applicant for Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II?

The FDA 510(k) record lists Roche Diagnostics as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II?

The FDA product code for Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II is KXT.

Other records listing Roche Diagnostics as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252323cobas pulse blood glucose monitoring systemPMA P990056Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancerPMA P000027PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERSK252431Elecsys CalcitoninK252280Elecsys Anti-SARS-CoV-2 SK260049Elecsys Anti-HBc IgM

View all 84 devices →

Related Devices (Code: KXT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K193397ADVIA Centaur® Digoxin assaySiemens Healthcare Diagnostics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑